The evidence-based recommendations described below outline the standard follow-up procedures for uveal melanoma surveillance and are intended to assist you in providing optimal cancer follow-up care for your patient; these recommendations are not intended to be a substitute for clinical judgement.
Primary Care Providers are asked to please continue systemic monitoring of their patient. As part of the minimum recommended follow-up, the patient requires indefinitely:
Patients should be referred back to their treating oncologist.
The table below outlines some common general complications of cancer treatment:
Year Since Treatment Completion
| Complication | Actions |
|---|---|
| Fatigue |
Fatigue should start to improve within months of treatment completion.
Persistent or recurrent fatigue warrants further work-up to rule out other potential causes. For more information please refer to the Cancer-Related Fatigue Guideline. Consider a referral to Alberta Cancer Exercise Program. |
| Psychosocial Distress |
Increasing helplessness/hopelessness, distress, anxiety or depression may be present. Patients experiencing these symptoms should be encouraged to inform their oncology treatment team for appropriate psychosocial referral. |
Specialist Link (Calgary/Southern Alberta)
ConnectMD (Edmonton/Northern Alberta)
Note: The information on this page was adapted from the AHS Guideline Resource Unit's Uveal Melanoma Guideline, as well as the accompanying Uveal Melanoma Class 1 Cancer Transfer of Care Physician Letter and Uveal Melanoma Class 2 Transfer of Care Physician.
